TSLP Inhibitors for Asthma: Current Status and Future Prospects Maria Gabriella MateraPaola RoglianiMario Cazzola Leading Article 20 February 2020 Pages: 449 - 458
Mechanisms of Resistance to PD-1 Checkpoint Blockade Justin C. MoserSiwen Hu-Lieskovan Leading Article 24 February 2020 Pages: 459 - 465
Glucokinase Activators for Type 2 Diabetes: Challenges and Future Developments Konstantinos A. ToulisKrishnarajah NirantharakumarAbd A. Tahrani Leading Article 11 March 2020 Pages: 467 - 475
Third-Line Antidiabetic Therapy Intensification Patterns and Glycaemic Control in Patients with Type 2 Diabetes in the USA: A Real-World Study Digsu N. KoyeOlga MontvidaSanjoy Ketan Paul Original Research Article 06 March 2020 Pages: 477 - 487
Cenegermin: A Review in Neurotrophic Keratitis Emma D. DeeksYvette N. Lamb Adis Drug Evaluation 18 March 2020 Pages: 489 - 494
Trastuzumab Deruxtecan: First Approval Susan J. Keam AdisInsight Report 07 March 2020 Pages: 501 - 508
Correction to: Ubrogepant: First Approval Lesley J. Scott Correction Open access 12 March 2020 Pages: 523 - 523
